Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oncology Institute (TOI) Times Interest Earned (2021 - 2025)

Oncology Institute (TOI) has disclosed Times Interest Earned for 5 consecutive years, with -$4.19 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Times Interest Earned rose 32.63% year-over-year to -$4.19, compared with a TTM value of -$3.9 through Sep 2025, up 49.14%, and an annual FY2024 reading of -$8.02, up 29.43% over the prior year.
  • Times Interest Earned was -$4.19 for Q3 2025 at Oncology Institute, up from -$6.0 in the prior quarter.
  • Across five years, Times Interest Earned topped out at -$1.78 in Q1 2025 and bottomed at -$300.07 in Q2 2022.
  • Average Times Interest Earned over 5 years is -$49.46, with a median of -$9.05 recorded in 2024.
  • The sharpest move saw Times Interest Earned plummeted 2077.9% in 2022, then skyrocketed 96.96% in 2023.
  • Year by year, Times Interest Earned stood at -$13.78 in 2021, then tumbled by 2077.9% to -$300.07 in 2022, then soared by 97.38% to -$7.88 in 2023, then decreased by 29.67% to -$10.21 in 2024, then surged by 58.93% to -$4.19 in 2025.
  • Business Quant data shows Times Interest Earned for TOI at -$4.19 in Q3 2025, -$6.0 in Q2 2025, and -$1.78 in Q1 2025.